Abstract
Introduction

Ischemia/reperfusion (I/R) injury consists of a complex series of processes ranging from metabolic to morphological and contrac-between nitric oxide and superoxide. Its detrimental action on the development of cardiac I/R injury, as well as its negative effects on cardiac systolic function, has been well established
. Nonetheless, the exact mechanisms by which ONOO Ϫ modulates I/R injury and systolic dysfunction remain to be explained. The nitration of cardiac proteins, including myofilament components such as troponin T and I, ␣ actin and myosin light chain 1 (MLC1), during I/R has been previously described [11] [12] [13] [14] [15] [16] ; however, the mechanism and molecular consequences of this modification remain unknown. Recent studies by Kanski and colleagues have shown that MLC1, a protein of the muscle contractile machinery, can be nitrated in cardiac [13] and skeletal muscle [17] [18] and hypoxia/ reoxygenation (H/R) [19] . MMP-2 is expressed ubiquitously in the heart, including the cardiac myocyte, and has been implicated in a variety of cardiovascular diseases [20] [21] [22] . MMP-2 exhibits both extracellular activity (degrading and remodelling of extracellular matrix) and intracellular activity, namely the degradation of myofibrillar proteins [23] [24] [25] 
due to biological aging, but the consequence of this modification has not been established. In addition, it has been well documented that myocardial MLC1 is degraded by matrix metalloproteinase-2 (MMP-2) during I/R injury
. Our most recent study on H/R, using an animal model of neonatal asphyxia, showed that the degradation of MLC1 by MMP-2 is associated with posttranslational modifications (PTMs) of MLC1 such as tyrosine nitration and cysteine S-nitrosylation [19]. This study suggested that nitration and/or nitrosylation might play an important regulatory role in controlling intracellular proteolytic action of MMP-2 in MLC1 degradation.
Based on our previous work we suggest that ischemia induces ONOO Ϫ -dependent MLC1 nitration/nitrosylation and that these modifications, together with increased intracellular MMP-2 activity, lead to increased degradation of MLC1 within the cardiomyocyte.
Materials and methods
This investigation conforms to the Guide to the Care and Use of Experimental Animals published by the Canadian Council on Animal Care.
Preparation of cardiomyocytes and simulated ischemia protocol
Myocyte isolation
Adult male Sprague-Dawley rats were anaesthetized with sodium pentobarbital (150 mg/kg i.p.) and hearts were removed. Right ventricular myocytes (VMs) were obtained by enzymatic dissociation as previously described [26] [27] [28] .
Simulated ischemia
Ischemia was induced by covering the cell pellets with a thin layer of mineral oil. This method is well established as a biological model of ischemia using isolated cardiomyocytes and is reviewed in [29] . At [18, 33, 34] . Developed gels were scanned using a GS-800 calibrated densitometer (BioRad) . Quantitative analysis of MLC1 protein spots' intensities from 2-DE gels were measured using PDQuest 7.1 software (BioRad). 
-hrs (approximately 260 min.). After IEF, the strips were equilibrated according to the manufacturer's instructions. A second dimension of 2-DE was then carried out with Criterion pre-cast gels (8-16%) (BioRad). After separation, proteins were stained with Silver Stain Plus kit (BioRad). To minimize variation in staining all gels were stained in the same bath. The reproducibility of 2-DE and quality of protein loading has been previously verified by us
Mass spectrometry
MLC1 protein spots were manually excised from the 2-DE gel. The spots containing rat cardiac MLC1 protein (2-DE) and preparations of human cardiac MLC1 protein from the in vitro study were processed using a MassPrep Station from Micromass using the methods supplied by the manufacturer. Mass analysis of the trypsin digest of MLC1 was performed on MALDI-TOF
Measurement of MMP-2 activity
Gelatine zymography was performed as described [36] . [37] .
Measurement of nitrotyrosine levels
Immunoblot analysis
Rat cardiac MLC1 and nitrotyrosine level was determined by immunoblot analysis. Protein (30 g) from isolated cardiomyocyte homogenate was separated using 12% SDS-PAGE [40] and transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad). MLC1 was identified using polyclonal anti-MLC1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Nitrotyrosine was identified using rabbit polyclonal anti-nitrotyrosine antibody (Cell Signaling Technology, Beverly, MA, USA). Band densities were measured using GS-800 calibrated densitometer and Quantity One 4.6 software.
Immunoprecipitation
Immunoprecipitation of MMP-2 and rat cardiac MLC1 was performed as previously described [19] . (Fig. 1 
Results
Effect of duration of ischemia on cardiomyocyte viability and contractility
After isolation, cardiomyocytes were subjected to 15, 60 or 120 min. of ischemia. In order to determine the times of ischemia for this study we evaluated cell viability at the end of the different ischemic times. After 15 min. of ischemia, cell viability and contractility were similar to control (Fig. 1). Sixty minutes of ischemia significantly reduced cell viability but to a lesser extent than 120 min. of ischemia (Fig. 1A). To further validate our model, we measured contractility of isolated rat cardiomyocytes. The goal of this experiment was to determine the contractile status of isolated cardiomyocytes after different times of ischemia. As seen in panel B
Peroxynitrite formation during ischemia in cardiomyocytes
The production of ONOO Ϫ was determined by measuring the lev- Fig. 2A) . Immunoblot analysis (Fig. 2B) showed association of increased levels of nitrotyrosines with increasing duration of ischemia. Figure 3A . As shown, the MLC1 level was significantly decreased in cells subjected to 60 min. of ischemia. Similarly, a significant reduction of the MLC1 level was observed by immunoblot analysis (Fig. 3B) . Figure 4A . A significant, progressive increase in total MMP-2 activity was observed after 15 and 60 min. of ischemia compared to control. (Fig. 4B) .
els of nitrotyrosine by HPLC and by immunoblotting in cardiomyocyets subjected to simulated ischemia and compared to the aerobic (control) myocytes. Analysis of the nitrotyrosine to tyrosine ratio showed a 2-fold increase in nitration of tyrosine during 60 min. of ischemia in comparison to the control group (
Increased nitration of tyrosine in the protein band corresponding to MLC1 standard (panel a) in both ischemic groups versus the control group (panel b) was observed.
Fig. 1 Effect of duration of ischemia on cardiomyocyte viability and contractility. (A) Cell viability after simulated ischemia. Viability was defined as the percentage of live cells. (B) Cell contractility (peak shortening) was
Analysis of MLC1 level and MMP-2 activity in cardiomyocytes
Two-dimensional polyacrylamide gel electrophoresis analysis of the MLC1 level in cardiomyocyte homogenates is presented in
The specific activities of the 72 and 62 kD isoforms of MMP-2 in myocyte homogenates from control and ischemic groups are illustrated in
Immunoprecipitation of MMP-2 protein with anti-MLC1 IgG followed by immunoblotting for MLC1 demonstrated that MLC1 co-localizes with MMP-2 and that the amount of the MMP-2-MLC1 complex (enzyme substrate) increases with duration of ischemia
Effect of ONOO
Ϫ on the degradation of recombinant human cardiac MLC1 by MMP-2 in vitro 
